Nicardipine Hydrochloride NDC 72572-470

NDC codes

FDA NDC Directory

Product NDC (as listed)72572-470Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72572-0470Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72572-470-10	72572047010	10 VIAL in 1 CARTON (72572-470-10) / 10 mL in 1 VIAL (72572-470-01)Marketed from Oct 29, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nicardipine Hydrochloride
Generic name (nonproprietary): nicardipine hydrochloride
Active ingredients: Nicardipine hydrochloride — 2.5 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Civica, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090534
Marketing start: Oct 29, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Dihydropyridines (Chemical structure)
Identifiers: Product ID 72572-470_fba70df6-5d37-4a12-bce3-e6fb1b0c72b2SPL ID fba70df6-5d37-4a12-bce3-e6fb1b0c72b2SPL set ID 30fb3a4d-fa75-42fd-b4b6-2a21f202027fRxCUI 858607UNII K5BC5011K3
Pharmacologic class: Dihydropyridine Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472572047010 followed by a unit qualifier and the quantity

Package 72572-0470-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2020.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE niCARdipine hydrochloride injection is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible. ( 1.1 ) 1.1 Hypertension niCARdipine Hydrochloride Injection, USP is indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable. For prolonged control of blood pressure, transfer patients to oral medication as soon as their clinical condition permits [see Dosage and Administration ( 2.1 )] .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090534

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090534
Product	Strength	Form · route	Labeler	Product NDC
Nicardipine Hydrochloride	Nicardipine hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-0735